|
HOOK1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.165200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.378730E-03 |
| Normal-vs-Stage2 |
4.177200E-01 |
| Normal-vs-Stage3 |
3.108600E-01 |
| Normal-vs-Stage4 |
3.102800E-03 |
| Stage1-vs-Stage2 |
3.458800E-01 |
| Stage1-vs-Stage3 |
7.810400E-04 |
| Stage1-vs-Stage4 |
3.3588000003526E-07 |
| Stage2-vs-Stage3 |
1.640220E-01 |
| Stage2-vs-Stage4 |
1.291650E-02 |
| Stage3-vs-Stage4 |
1.185360E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.312200E-01 |
| Normal-vs-AfricanAmerican |
9.400000E-01 |
| Normal-vs-Asian |
6.059600E-01 |
| Caucasian-vs-AfricanAmerican |
4.178000E-01 |
| Caucasian-vs-Asian |
7.305600E-01 |
| AfricanAmerican-vs-Asian |
4.562800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.486200E-01 |
| Normal-vs-Female |
2.701000E-03 |
| Male-vs-Female |
5.595700E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.987600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.581420E-01 |
| Normal-vs-Age(61-80Yrs) |
4.588800E-01 |
| Normal-vs-Age(81-100Yrs) |
7.211800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.855380E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.633800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.594200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.569000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.308200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.309400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.508020E-02 |
| Normal-vs-Grade 2 |
1.354410E-04 |
| Normal-vs-Grade 3 |
2.689200E-01 |
| Normal-vs-Grade 4 |
7.42450000368322E-08 |
| Grade 1-vs-Grade 2 |
1.526160E-01 |
| Grade 1-vs-Grade 3 |
9.496500E-03 |
| Grade 1-vs-Grade 4 |
6.983700E-04 |
| Grade 2-vs-Grade 3 |
3.86829999998728E-06 |
| Grade 2-vs-Grade 4 |
1.82198700571234E-12 |
| Grade 3-vs-Grade 4 |
2.29959999999974E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.03170003043596E-09 |
| Normal-vs-ccB subtype |
1.623400E-04 |
| ccA subtype-vs-ccB subtype |
1.6251444634463E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.018000E-01 |
| Normal-vs-N1 |
1.379420E-01 |
| N0-vs-N1 |
1.081980E-01 |
|
|
